Shares of Can-Fite BioPharma Ltd. (CANF) are rising over 33% in pre-market today, after the company announced that it has amended the protocol for its Phase II COVID-19 study based on the U.S. FDA feedback.
from RTT - Before the Bell https://ift.tt/309UEYg
via IFTTT
No comments:
Post a Comment